日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer

利用无组织表观基因组学检测方法检测循环肿瘤DNA是早期三阴性乳腺癌的一种高度预后生物标志物

Ademuyiwa, Foluso O; Ma, Cynthia X; Weilbaecher, Katherine; Suresh, Rama; Peterson, Lindsay L; Bose, Ron; Bagegni, Nusayba; Rigden, Caron E; Frith, Ashley; Clifton, Katherine; Dustin, Derek; Cai, Mingyang; Xiong, Liyang; Chen, Sai; Davis, Andrew A

HER2-Low and HER2-Ultralow Metastatic Breast Cancer and Trastuzumab Deruxtecan: Common Clinical Questions and Answers

HER2低表达和HER2超低表达转移性乳腺癌及曲妥珠单抗德鲁替康:常见临床问题及解答

Bagegni, Nusayba A; Giridhar, Karthik V; Stewart, Daphne

The clinical implications of the interaction between hypothyroidism and diabetes mellitus

甲状腺功能减退症与糖尿病相互作用的临床意义

Elhussein, Amar Babikir; Dawod, Ogail Yousif; Abu, Ibrahim Ismail Mohammed; Babikr, Walid G; Alsayegh, Abdulrahman A; Otayf, Abdullah Y; Bajahzer, Mohammed F; Mondal, Monami Mukherjee; Alageb, Nusayba Abdelrhman; Almaki, Mohamed M; Ahmed, Badreldin S R; Abdelmola, Ammar; Abdalla, Saif Elden B; Elmobark, Mohamed Eltaib; Elbadawi, Nour Eldaim Elnoman; Homeida, Husham E; Elamin, Nahid Mahmoud Hassan; Alhassen, Muntaser Mohammed Fadoul; Khalid, Asaad

Post-coronavirus Disease 2019 (COVID-19) Cardiovascular Manifestations: A Systematic Review of Long-Term Risks and Outcomes

2019冠状病毒病(COVID-19)后心血管表现:长期风险和结局的系统评价

Idris Fadul, Alaa Abdallah; Osman Mohamed, Areij Awad; Mohammed Ahmed, Ahmed Abdullahi Sidahmed; Elmobark, Sara; Merghani Hammour, Amjad Saeed; Elgaleel Khir Elsiad, Nusayba Mustafa Nour; Mohammed Elhaj, Ebtihal Abdalglil

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

palbociclib 加来曲唑加曲妥珠单抗作为临床 II 期和 III 期 ER+ HER2+ 乳腺癌新辅助治疗的 II 期研究 (PALTAN)

Ademuyiwa, Foluso O; Northfelt, Donald W; O'Connor, Tracey; Levine, Ellis; Luo, Jingqin; Tao, Yu; Hoog, Jeremy; Laury, Marie L; Summa, Tracy; Hammerschmidt, Trish; Guo, Zhanfang; Frith, Ashley; Weilbaecher, Katherine; Opyrchal, Mateusz; Aft, Rebecca; Clifton, Katherine; Suresh, Rama; Bagegni, Nusayba; Hagemann, Ian S; Iglesia, Michael D; Ma, Cynthia X

Vitamin D knowledge, awareness and practices of female students in the Southwest of Saudi Arabia: A cross-sectional study

沙特阿拉伯西南部女大学生维生素D知识、意识和实践:一项横断面研究

Kambal, Nahla; Abdelwahab, Siddig; Albasheer, Osama; Taha, Sara; Abdelrahman, Nusayba; Bani, Ibrahim; Alsayegh, Abdulrahman; Shammaky, Eithar; Duwayri, Nawal; Alhazmi, Alaa; Mahzari, Maryam; Hakami, Nasser

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

转移性乳腺癌患者浸润性小叶癌的循环肿瘤DNA特征分析

Davis, Andrew A; Gerratana, Lorenzo; Clifton, Katherine; Medford, Arielle J; Velimirovic, Marko; Hensing, Whitney L; Bucheit, Leslie; Shah, Ami N; D'Amico, Paolo; Reduzzi, Carolina; Zhang, Qiang; Dai, Charles S; Denault, Elyssa N; Bagegni, Nusayba A; Opyrchal, Mateusz; Ademuyiwa, Foluso O; Bose, Ron; Gradishar, William J; Behdad, Amir; Ma, Cynthia X; Bardia, Aditya; Cristofanilli, Massimo

Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab

针对高危早期三阴性乳腺癌的靶向治疗:聚焦帕博利珠单抗

Bagegni, Nusayba A; Davis, Andrew A; Clifton, Katherine K; Ademuyiwa, Foluso O

Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature

奈拉替尼治疗HER2阳性乳腺癌患者腹泻的管理:病例系列及文献综述

Kruse, Megan L; Kang, Irene M; Bagegni, Nusayba A; Howell, W Todd; Moore, Halle C F; Bedell, Cynthia H; Stokoe, Christopher T

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors

抗 VEGF/PDGFR 药物 vorolanib 联合免疫检查点抑制剂治疗晚期实体瘤患者的 1b 期试验

Bagegni, Nusayba A; Park, Haeseong; Kraft, Katlyn; O-Toole, Maura; Gao, Feng; Waqar, Saiama N; Ratner, Lee; Morgensztern, Daniel; Devarakonda, Siddhartha; Amin, Manik; Baggstrom, Maria Q; Liang, Chris; Selvaggi, Giovanni; Wang-Gillam, Andrea